Pharmaceuticals Department notifies revisions to sub-scheme ‘Revamped Pharmaceutical Technology Upgradation Assistance Scheme’: Increases incentive cap and simplifies application process for Pharma MSMEs by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsDepartment of Pharmaceuticals has notified modifications under the sub-scheme “Revamped... Read More
CDSCO mandates online-only submissions in Form-44 for veterinary drugs through SUGAM portal, ending offline options by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsWith a view to streamline the regulatory submission procedure, the veterinary division of the... Read More
CDSCO invites public comments on Draft Guidelines for Good Clinical Practices till 12th October 2024 by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Central Drugs Standard Control Organization (“CDSCO”) has invited comments/suggestions on... Read More
NPPA revises ceiling price of Chloroquine (150mg) tablet price to Rs. 1.33 per tablet; manufacturers directed to align pricing with ceiling price by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe National Pharmaceutical Pricing Authority (“NPPA”), after reviewing the Wholesale... Read More
Centre notifies Uniform Code for Marketing Practices in Medical Devices 2024; mandates annual self-declarations on Code adherence and disclosure of expenses on medical education/conferences and free samples through UCPMP portal by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Department of Pharmaceuticals has notified the Uniform Code for Marketing Practices in Medical... Read More
Pharmaceutical companies mandated to disclose free sample and continuing medical education /conference related expenses on UCPMP portal within two months of financial year-end by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Department of Pharmaceuticals has directed pharmaceutical companies to submit a declaration... Read More